463 related articles for article (PubMed ID: 33123092)
1. Sex-Specific Differences in the Association of Metabolically Healthy Obesity With Hyperuricemia and a Network Perspective in Analyzing Factors Related to Hyperuricemia.
Tian S; Liu Y; Feng A; Zhang S
Front Endocrinol (Lausanne); 2020; 11():573452. PubMed ID: 33123092
[TBL] [Abstract][Full Text] [Related]
2. Metabolically healthy obesity also has risk for hyperuricemia among Chinese general population: A cross-sectional study.
Chen Y; Zhang N; Sun G; Guo X; Yu S; Yang H; Zheng L; Sun Y
Obes Res Clin Pract; 2016 Sep; 10 Suppl 1():S84-S95. PubMed ID: 27061989
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia as an effect modifier of the association between metabolic phenotypes and nonalcoholic fatty liver disease in Chinese population.
Zheng J; Li X; Zhang Y; Miao Y; Zhang Q
J Transl Med; 2023 Jan; 21(1):39. PubMed ID: 36681819
[TBL] [Abstract][Full Text] [Related]
4. Transition patterns of metabolism-weight phenotypes over time: A longitudinal study using the multistate Markov model in China.
Zhang H; Tang X; Hu D; Li G; Song G
Front Public Health; 2022; 10():1026751. PubMed ID: 36589938
[TBL] [Abstract][Full Text] [Related]
5. Metabolically healthy obesity is associated with higher risk of both hyperfiltration and mildly reduced estimated glomerular filtration rate: the role of serum uric acid in a cross-sectional study.
Zhang H; Chen R; Xu X; Yang M; Xu W; Xiang S; Wang L; Jiang X; Hua F; Huang X
J Transl Med; 2023 Mar; 21(1):216. PubMed ID: 36959674
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children.
Genovesi S; Antolini L; Orlando A; Gilardini L; Bertoli S; Giussani M; Invitti C; Nava E; Battaglino MG; Leone A; Valsecchi MG; Parati G
Front Endocrinol (Lausanne); 2020; 11():27. PubMed ID: 32117055
[No Abstract] [Full Text] [Related]
7. Metabolic abnormalities, but not obesity per se, associated with chronic kidney disease in a Taiwanese population.
Chen HY; Lu FH; Chang CJ; Wang RS; Yang YC; Chang YF; Wu JS
Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):418-425. PubMed ID: 31744713
[TBL] [Abstract][Full Text] [Related]
8. Hyperuricemia is Associated with the Presence of Metabolically Obese Normal-Weight and Metabolically Healthy Obese Phenotypes.
Guerrero-Romero F; Simental-Mendía LE
Endocr Res; 2022; 47(3-4):124-129. PubMed ID: 35918814
[TBL] [Abstract][Full Text] [Related]
9. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
[TBL] [Abstract][Full Text] [Related]
10. A Bayesian Network Analysis of the Probabilistic Relationships Between Various Obesity Phenotypes and Cardiovascular Disease Risk in Chinese Adults: Chinese Population-Based Observational Study.
Tian S; Bi M; Bi Y; Che X; Liu Y
JMIR Med Inform; 2022 Mar; 10(3):e33026. PubMed ID: 35234651
[TBL] [Abstract][Full Text] [Related]
11. Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition.
Barrea L; Muscogiuri G; Pugliese G; de Alteriis G; Colao A; Savastano S
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836180
[TBL] [Abstract][Full Text] [Related]
12. Association between metabolic phenotype and urinary albumin-creatinine ratio in Chinese community adults: A cross-sectional study.
Zhang Y; Li B; Liu Y; Gao W; Chen K; Wang A; Tang X; Yan L; Luo Z; Qin G; Chen L; Wan Q; Gao Z; Wang W; Ning G; Mu Y
J Diabetes; 2022 Aug; 14(8):541-550. PubMed ID: 36040203
[TBL] [Abstract][Full Text] [Related]
13. Comparative analyses of surrogates of metabolic syndrome in children and adolescents with metabolically healthy obesity vs. metabolically unhealthy obesity according to Damanhoury's criteria.
Mohamad R; Cakir AD; Ada Hİ; Uçar A
J Pediatr Endocrinol Metab; 2023 May; 36(5):451-457. PubMed ID: 37017079
[TBL] [Abstract][Full Text] [Related]
14. The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study.
Zakerkish M; Hoseinian A; Alipour M; Payami SP
BMC Endocr Disord; 2023 May; 23(1):122. PubMed ID: 37246210
[TBL] [Abstract][Full Text] [Related]
15. The effect of metabolic health and obesity phenotypes on risk of hypertension: A nationwide population-based study using 5 representative definitions of metabolic health.
Tian S; Xu Y; Dong H
Medicine (Baltimore); 2018 Sep; 97(38):e12425. PubMed ID: 30235720
[TBL] [Abstract][Full Text] [Related]
16. Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype.
Kang YM; Jung CH; Cho YK; Jang JE; Hwang JY; Kim EH; Lee WJ; Park JY; Kim HK
PLoS One; 2017; 12(6):e0179635. PubMed ID: 28644850
[TBL] [Abstract][Full Text] [Related]
17. Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk.
Nasereldin DS; White LJ; Hodge DO; Roberts LR; Patel T; Antwi SO
Dig Liver Dis; 2022 Jul; 54(7):964-972. PubMed ID: 34953761
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive metabolic profiling of the metabolically healthy obesity phenotype.
Telle-Hansen VH; Christensen JJ; Formo GA; Holven KB; Ulven SM
Lipids Health Dis; 2020 May; 19(1):90. PubMed ID: 32386512
[TBL] [Abstract][Full Text] [Related]
19. Association between metabolic overweight/obesity phenotypes and readmission risk in patients with lung cancer: A retrospective cohort study.
Yuan Z; Cheng Y; Han J; Wang D; Dong H; Shi Y; Poulsen KL; Fan X; Zhao J
EClinicalMedicine; 2022 Sep; 51():101577. PubMed ID: 35898319
[TBL] [Abstract][Full Text] [Related]
20. Adherence to the Mediterranean diet as a possible additional tool to be used for screening the metabolically unhealthy obesity (MUO) phenotype.
Barrea L; Verde L; Simancas-Racines D; Zambrano AK; Frias-Toral E; Colao A; Savastano S; Muscogiuri G
J Transl Med; 2023 Sep; 21(1):675. PubMed ID: 37770999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
